Blog Full Right Sidebar

With Frame
HDFC Securities has an ‘add’ call on Dr Lal Pathlabs with a target price of Rs 2910. The company reported a total income of Rs 621.80 crore for the quarter ending 31-12-2024, marking an 11.59% increase from the same quarter last year. The diagnostic sector’s de-rating and moderate earnings growth influenced the latest valuation estimates.
Read More
Shares in Chinese EV giant BYD surged to a record high Tuesday after it unveiled new battery technology it says can charge a vehicle in the same time it takes to fill up a petrol car. Separately, on Tuesday, Chinese EV maker Nio said it had signed a deal with battery giant CATL involving cooperation on a passenger car battery swap network.
Read More
1 3,688 3,689 3,690 3,691 3,692 3,698

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Recent News

Monarch Networth says Nifty can hit 28,000 in 2026, picks three top stocks
June 15, 2026
Oil slide sends India’s benchmark yield to two-month low
June 15, 2026
Madhusudan Kela buys luxury flat for Rs 121 cr in DLF’s Gurugram project
June 15, 2026

Recent Cases